drugset / Trial / NCT03573024
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
NaSingle-groupOpen-labelTreatment
Summary
This study aims to treat non-elderly adult patients, who were previously untreated for acute myeloid leukemia, using venetoclax and azacitidine.
Timeline
- Start
- 2018-11-28
- Primary completion
- 2025-04-14
- Completion
- 2026-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | Subcutaneous |
| Subject | Venetoclax | Small molecule | 600 mg | Oral |